Pancreatic Cancer Research

ResearcherMilitary Medical AcademyActive in the last 2 years

Nebojsa S. Manojlovic

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3639-1328; OpenAlex author ID A5039975788. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Neoadjuvant treatment of pancreatic ductal adenocarcinoma: Whom, when and how. Co-author DOI 10.4240/wjgs.v16.i5.1223↗
  2. Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer. Co-author DOI 10.1002/ijc.31603↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Stevan Manojlovic · 1 shared paper, 2024 · strength 0.36
  2. Chris Verslype · 1 shared paper, 2018 · strength 0.07
  3. Manuel M. Hidalgo · 1 shared paper, 2018 · strength 0.07
  4. Dejan V. Radenkovic · 1 shared paper, 2018 · strength 0.07
  5. Antonio Cubillo · 1 shared paper, 2018 · strength 0.07
  6. Éric Raymond · 1 shared paper, 2018 · strength 0.07
  7. Pascal R. Hammel · 1 shared paper, 2018 · strength 0.07
  8. Eric Van Cutsem · 1 shared paper, 2018 · strength 0.07
  9. Teresa Mercade Macarulla · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.